Dyslipidemia remains a major contributor to cardiovascular disease, and pharmacists play a key role in optimizing therapy and improving outcomes. This episode reviews recent updates in guidelines, pharmacologic options, and practical counseling tips for supporting patients with lipid disorders. Tune in to strengthen your clinical impact and support long-term health for the patients you serve.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Janelle Ruisinger, PharmD, FAPhA
Clinical Professor
The University of Kansas School of Pharmacy


CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current guidelines and evidence-based pharmacologic options for managing dyslipidemia.
2. Identify key counseling strategies pharmacists can use to support adherence and improve lipid-related outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-226-H01-P
Initial release date: 6/30/2025
Expiration date: 6/30/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram